Matches in Wikidata for { <http://www.wikidata.org/entity/Q61778563> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q61778563 description "article scientifique publié en 2013" @default.
- Q61778563 description "artículu científicu espublizáu en mayu de 2013" @default.
- Q61778563 description "im Mai 2013 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61778563 description "scientific article published on 04 May 2013" @default.
- Q61778563 description "wetenschappelijk artikel" @default.
- Q61778563 description "наукова стаття, опублікована в липні 2013" @default.
- Q61778563 name "A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory Acute Leukemia" @default.
- Q61778563 name "A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory Acute Leukemia" @default.
- Q61778563 type Item @default.
- Q61778563 label "A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory Acute Leukemia" @default.
- Q61778563 label "A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory Acute Leukemia" @default.
- Q61778563 prefLabel "A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory Acute Leukemia" @default.
- Q61778563 prefLabel "A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory Acute Leukemia" @default.
- Q61778563 P1433 Q61778563-FFCC5F2A-B884-4CBC-B5DA-1F9D07B26161 @default.
- Q61778563 P1476 Q61778563-E4354A7F-586A-489C-ABB4-535315D6BD47 @default.
- Q61778563 P2093 Q61778563-304265C5-C496-44FC-8E4E-03220D38D054 @default.
- Q61778563 P2093 Q61778563-4F9F7A92-042C-42BF-9C10-7F70ECFE1BBA @default.
- Q61778563 P2093 Q61778563-57C9904F-354C-4B63-BE91-BC8016601967 @default.
- Q61778563 P2093 Q61778563-5E12DBB6-BBB0-4A9F-9794-68940AF8899C @default.
- Q61778563 P2093 Q61778563-67E95A6F-203F-4A9A-84A3-353694593951 @default.
- Q61778563 P2093 Q61778563-87A07167-3A4B-4A7F-B4E7-E426CCF52792 @default.
- Q61778563 P2093 Q61778563-8DC0270B-1C19-4DEE-8E53-425A3479AE85 @default.
- Q61778563 P2093 Q61778563-9CCF8270-F4CD-432C-8198-A918A214D37D @default.
- Q61778563 P2093 Q61778563-BDD5C26F-32DF-4CC1-8C58-AE132A9E1909 @default.
- Q61778563 P2093 Q61778563-ED24A1D3-9784-48B8-8B5B-E8AF866F8E13 @default.
- Q61778563 P304 Q61778563-F96DE3F0-7CA6-44D8-9300-5FC2FA88BA6A @default.
- Q61778563 P31 Q61778563-2DDD22FF-5154-43FE-A3B8-EA41B2855EF2 @default.
- Q61778563 P356 Q61778563-3356C743-EE90-4F7A-B790-BAF5155D1F03 @default.
- Q61778563 P433 Q61778563-7ECCE432-524C-423F-B10A-FFD6597DB4AC @default.
- Q61778563 P478 Q61778563-6E817914-8CB8-4AD7-A794-BE2E2EECBF82 @default.
- Q61778563 P50 Q61778563-27D597E1-55D7-4FCF-A144-509C7A2C29CB @default.
- Q61778563 P50 Q61778563-8907DF60-4270-4590-B91C-5B8BA53C7B5E @default.
- Q61778563 P50 Q61778563-B132D3DD-840E-4FB0-9839-D54D32960EFD @default.
- Q61778563 P577 Q61778563-367ED04F-C3FB-4972-BFE2-2EEB0C3CBCF5 @default.
- Q61778563 P698 Q61778563-36563AA7-F511-43CD-BB73-3742F22B55C3 @default.
- Q61778563 P921 Q61778563-0E193D6C-0650-4110-95C0-881192A02CB0 @default.
- Q61778563 P921 Q61778563-4A38DE5F-70B2-4300-AF03-93D48609ED79 @default.
- Q61778563 P921 Q61778563-5E54580C-D30C-4298-9C47-A127070A77E0 @default.
- Q61778563 P921 Q61778563-E3455E4F-D273-48A0-BF9E-C782585B45DE @default.
- Q61778563 P356 J.BBMT.2013.04.013 @default.
- Q61778563 P698 23648237 @default.
- Q61778563 P1433 Q15754328 @default.
- Q61778563 P1476 "A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemia" @default.
- Q61778563 P2093 "Ellen Ritchie" @default.
- Q61778563 P2093 "Eric Feldman" @default.
- Q61778563 P2093 "Gail Roboz" @default.
- Q61778563 P2093 "Marshall McKenna" @default.
- Q61778563 P2093 "Paul Christos" @default.
- Q61778563 P2093 "Roger Pearse" @default.
- Q61778563 P2093 "Sebastian Mayer" @default.
- Q61778563 P2093 "Tomer Mark" @default.
- Q61778563 P2093 "Usama Gergis" @default.
- Q61778563 P2093 "Usama Wissa" @default.
- Q61778563 P304 "1040-1045" @default.
- Q61778563 P31 Q13442814 @default.
- Q61778563 P356 "10.1016/J.BBMT.2013.04.013" @default.
- Q61778563 P433 "7" @default.
- Q61778563 P478 "19" @default.
- Q61778563 P50 Q37382335 @default.
- Q61778563 P50 Q43263315 @default.
- Q61778563 P50 Q57542116 @default.
- Q61778563 P577 "2013-05-04T00:00:00Z" @default.
- Q61778563 P698 "23648237" @default.
- Q61778563 P921 Q103824 @default.
- Q61778563 P921 Q29496 @default.
- Q61778563 P921 Q65592366 @default.
- Q61778563 P921 Q976388 @default.